An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

Full description

Saved in:
Bibliographic Details
Main Authors: Sasithon Pukrittayakamee, Podjanee Jittamala, Kasia Stepniewska, Niklas Lindegardh, Sunee Chueasuwanchai, Wattana Leowattana, Aphiradee Phakdeeraj, Sutatip Permpunpanich, Warunee Hanpithakpong, Wirichada Pan-Ngum, Caroline Fukuda, Salwaluk Panapipat, Pratap Singhasivanon, Nicholas J. White, Nicholas P J Day
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Medicine
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/12344
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/12344

Similar Items